about
Molecular basis of human CD36 gene mutationsCardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium ChannelsPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusResveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities.Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.In vivo functional NMR imaging of resistance artery control.Association between insulin resistance and endothelial dysfunction in renal transplant recipients.Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjectsEvidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complicationsExercise training improves cardiovascular autonomic modulation in response to glucose ingestion in obese adults with and without type 2 diabetes mellitus.Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study.Metabolomic analyses for atherosclerosis, diabetes, and obesity.AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesisInsulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI studyStem cells in the diabetic infarcted heartBlood flow and muscle metabolism: a focus on insulin action.Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis.Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.Alcohol, nutrition and health maintenance: selected aspects.Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.Interaction of physiological mechanisms in control of muscle glucose uptake.Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium.The heart in obesity-hypertension.The interaction effects of aerobic exercise training and vitamin D supplementation on plasma lipid profiles and insulin resistance in ovariectomized rats.Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates.Is insulin resistance the cause of the metabolic syndrome?Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?Characteristics of metabolically obese normal-weight (MONW) subjects.The insulin resistance syndrome: physiological considerations.Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosusInteractions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice.
P2860
Q24683083-B2619625-8024-4F97-9083-252F55902AC5Q26751133-1B8B0008-77E5-4054-A87B-0F4664B271A2Q26799591-0B395D0E-2A31-4B2E-A89E-BEC1388909ACQ26829529-75FAA88C-C51B-4B47-AE12-3A0CE396D5E0Q29347074-B72432E9-DAD1-4DE3-91B0-A5675A814F98Q30434274-B57C883D-9E92-47F9-8C35-B229DD2CE883Q30982569-06A6A82D-85BD-4B1B-83E1-4F150F305756Q33241175-EFECC695-DC05-4156-893D-89644860D761Q33307491-6CE2BD07-14E8-49C7-A5F0-F916EED72388Q33723943-F2D0A102-91EC-44FE-95B8-78454FAE9B3EQ33811283-B1A1C143-57ED-49E7-84CA-74CADB84E80EQ33816859-219E1444-1580-4909-9ABD-42F99C248D7AQ33872336-FCD749E9-BEA7-4510-8A73-E2A7A4869AEAQ34070479-D5E321F0-8919-441A-863E-567F7D8E20D6Q34179142-30D34EE3-9744-4B5E-8EEC-C3F0579C1A63Q34256164-660FE7D3-4359-45E8-8B48-29312665A892Q34310675-6EA6FB79-5A7E-49BB-8536-0381CA116636Q34408930-57977730-2FAD-46F6-ABAD-C259C09BB870Q34448739-13019625-969C-4D19-A00A-6D08BBA82136Q34773408-5DCDD4F4-B2B0-4DFF-BF8A-6355C00FB664Q35047244-6ABF1D03-8C1D-4E14-BF61-193C6BEEE966Q35581083-FAED4DD6-2882-4A4B-8CCD-FA6358008D07Q35588998-6F92C301-0C48-478B-BD4F-217A4570C4C0Q35740502-12A47E83-B0FF-47D3-8C8D-CBF105846EA7Q35837905-8FE4FA68-2B17-48D9-BA58-CC44C5DD47D8Q36089388-A5A9867D-94F7-46B7-BF34-C3E198868987Q36109641-B9A421C6-4662-4054-B061-EABAF41E9963Q36216822-DAFD6C7C-2FCC-41A1-8895-124B9791D222Q36218598-F48C9239-98F0-47DC-BC29-54A595ED97C5Q36309437-054E75C8-36EE-4ACA-991E-9A13E4036C89Q36383033-E936DC88-8FDD-49AD-B864-A7134BF87A84Q36407394-BCEC3D89-9DB6-4173-AD90-95D61FF8C4F9Q36492059-79E8DCCD-44FE-44E3-8B32-2B0641877B3DQ36628173-7C3BD503-2C25-4610-84E9-FD978BCBDDE1Q36749229-DE68D6DC-E07B-4C7E-9BDD-2B5C11E110AFQ36806509-43536418-9E07-457E-83DB-ECF06C3FE411Q36934234-81947572-A32A-43DA-8F1E-841F777BB4ADQ36966063-504D689E-B76E-4BA3-9336-8836E5AF2CA8Q37107490-A196D3A4-0FB2-4074-A989-52B97F7DEAA1Q37163044-677C208C-545B-4679-A24D-80D86E0A7557
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vascular function, insulin resistance and fatty acids.
@ast
Vascular function, insulin resistance and fatty acids.
@en
Vascular function, insulin resistance and fatty acids.
@nl
type
label
Vascular function, insulin resistance and fatty acids.
@ast
Vascular function, insulin resistance and fatty acids.
@en
Vascular function, insulin resistance and fatty acids.
@nl
prefLabel
Vascular function, insulin resistance and fatty acids.
@ast
Vascular function, insulin resistance and fatty acids.
@en
Vascular function, insulin resistance and fatty acids.
@nl
P1433
P1476
Vascular function, insulin resistance and fatty acids.
@en
P2093
Steinberg HO
P2888
P304
P356
10.1007/S00125-002-0800-2
P577
2002-04-04T00:00:00Z
P5875
P6179
1049161839